Advertisement

Topics

Strong Q2 growth for Sanofi raises 2017 sales outlook

04:57 EDT 31 Jul 2017 | Pharmafile

Sanofi exuded renewed confidence in its updated forecast for 2017 on the back of a Q2 report which illustrated strong growth for the French company, particularly in its vaccines and consumer health divisions, as well as Genzyme, its speciality care global business.

read more

Original Article: Strong Q2 growth for Sanofi raises 2017 sales outlook

NEXT ARTICLE

More From BioPortfolio on "Strong Q2 growth for Sanofi raises 2017 sales outlook"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Sanofi-Aventis
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...